New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
08:21 EDTNWBONorthwest Biotherapeutics' DCVax for tumors shows positive Phase I/II results
Northwest Biotherapeutics announced that, in the ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors, all 9 out of 9 patients who have received 4 of the 6 planned injections are showing tumor cell death, tumor shrinkage, substantial immune cell accumulation in their tumors and/or stabilization of their advanced cancer. In addition, in 3 of these 9 patients, biopsies now show no live tumor cells in the injected tumor. The company plans to report more details when the patients are further along in the treatment regimen.
News For NWBO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
06:09 EDTNWBOStocks with implied volatility movement; NWBO ZIOP
Subscribe for More Information
February 25, 2015
10:12 EDTNWBOHigh option volume stocks
High option volume stocks: WBAI HDS ICON NWBO RGR GFI RKT TJX RSG LC
February 19, 2015
12:57 EDTNWBONW Bio Phase III clinical trial of DCVax-L approved to proceed in Canada
Subscribe for More Information
February 17, 2015
10:29 EDTNWBOHigh option volume stocks
High option volume stocks: RDSA JACK WUBA MT JAKK VDSI ECL ENR AVG NWBO

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use